Posts Tagged ‘neumonía’

Tuesday February 17th, 2015

The use of anti-inflammatory drugs significantly reduces treatment failure in severe pneumonia

The use of corticosteroids, a group of anti-inflammatory drugs, along with antibiotics, significantly reduces treatment failure among patients with severe community-acquired pneumonia from 31% to 13 %, at the same time that improves their prognosis. The Journal of the American Medical Association (JAMA) publishes this study led by researchers from Hospital Clínic of Barcelona, IDIBAPS and the Networked Biomedical Research Center for Respiratory Diseases (CIBERES). Dr. Antoni Torres, Pneumologist at Hospital Clínic of Barcelona, professor at the University of Barcelona and coordinator of the IDIBAPS and CIBERES group that has led this research, is the first author of the paper.

Read the rest of this entry »

Comments Closed
Tuesday February 17th, 2009

New European consensus document for management of hospital pneumonia

Dr. Antoni Torres

Considerable disagreement persists regarding hospital-acquired pneumonia and ventilator-associated pneumonia. This circumstance has led to the initiative to create a consensus document that unifies the criteria of the 3 main European societies linked to these diseases—the European Respiratory Society (ERS), the European Society of Clinical Microbiology and Infectious Diseases and the European Society of Intensive Care Medicine. The person chosen to coordinate this project and represent the ERS was Dr. Antoni Torres, head of the respiratory medicine department of Hospital Clínic, Barcelona and leader of the research team on the spiritual diseases at the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). He is the principal author of the article published in the Journal Intensive Care Medicine (35:9-29), which lists the 20 points of agreement that were reached.

Read the rest of this entry »

Comments Closed